Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms

Published:2017-08-05 Issue:5 Volume:106 Page:691-703
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Taniguchi Yasuhiro,Tanaka Hirokazu,Luis Espinoza J.,Sakai Kazuko,Kumode Takahiro,Sano Keigo,Serizawa Kentarou,Rai Shinya,Morita Yasuyoshi,Hanamoto Hitoshi,Tsubaki Kazuo,Nishio Kazuto,Matsumura Itaru

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/s12185-017-2302-5/fulltext.html

Reference35 articles.

1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405.

2. Schnittger S, Bacher U, Haferlach C, Geer T, Müller P, Mittermüller J, Petrides P, Schlag R, Sandner R, Selbach J, et al. Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera. Haematologica. 2009;94(3):414–8.

3. Milosevic JD, Kralovics R. Genetic and epigenetic alterations of myeloproliferative disorders. Int J Hematol. 2013;97(2):183–97.

4. Nangalia J, Massie CE, Baxter EJ, Nice FL, Gundem G, Wedge DC, Avezov E, Li J, Kollmann K, Kent DG, et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med. 2013;369(25):2391–405.

5. Imai M, Araki M, Komatsu N. Somatic mutations of calreticulin in myeloproliferative neoplasms. Int J Hematol. 2017;105(6):743–7.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms;Clinical and Experimental Medicine;2024-05-22

2. Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology;Diagnostics;2023-01-03

3. Extracellular Vesicles in Haematological Disorders: A Friend or a Foe?;International Journal of Molecular Sciences;2022-09-04

4. Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH;Clinical and Translational Oncology;2021-11-30

5. A Specific Host/Microbial Signature of Plasma-Derived Extracellular Vesicles Is Associated to Thrombosis and Marrow Fibrosis in Polycythemia Vera;Cancers;2021-10-02